Marianne P. Allen

Array ( [id] => 10830779 [patent_doc_number] => 08858940 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'Amino acid sequences directed against the Angiopoietin/Tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis' [patent_app_type] => utility [patent_app_number] => 13/133685 [patent_app_country] => US [patent_app_date] => 2009-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 91071 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13133685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6502541 [patent_doc_number] => 20100260672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (CMET) AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/635193 [patent_app_country] => US [patent_app_date] => 2009-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 46073 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260672.pdf [firstpage_image] =>[orig_patent_app_number] => 12635193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6413996 [patent_doc_number] => 20100166874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Technology for Preparation of Macromolecular Microspheres' [patent_app_type] => utility [patent_app_number] => 12/633773 [patent_app_country] => US [patent_app_date] => 2009-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36542 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166874.pdf [firstpage_image] =>[orig_patent_app_number] => 12633773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228895 [patent_doc_number] => 20100183633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'INTERLEUKIN 6 AND TUMOR NECROSIS FACTOR ALPHA AS BIOMARKERS OF JNK INHIBITION' [patent_app_type] => utility [patent_app_number] => 12/631335 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 28594 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183633.pdf [firstpage_image] =>[orig_patent_app_number] => 12631335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8188329 [patent_doc_number] => 08182811 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Antibodies to CXCL13' [patent_app_type] => utility [patent_app_number] => 12/631170 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36630 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/182/08182811.pdf [firstpage_image] =>[orig_patent_app_number] => 12631170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134457 [patent_doc_number] => 20110008359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'MONOCLONAL ANTIBODIES AGAINST ANGPTL4' [patent_app_type] => utility [patent_app_number] => 12/631598 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 35423 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008359.pdf [firstpage_image] =>[orig_patent_app_number] => 12631598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7766896 [patent_doc_number] => 20120034604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'USE OF BASIC PROLIN-RICH LACRIMAL GENE PRODUCTS, SUCH AS OPIORPHIN, AS A BIOMARKER' [patent_app_type] => utility [patent_app_number] => 13/131470 [patent_app_country] => US [patent_app_date] => 2009-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10411 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034604.pdf [firstpage_image] =>[orig_patent_app_number] => 13131470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9126903 [patent_doc_number] => 08574851 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => 'Prediction and prevention of preeclampsia' [patent_app_type] => utility [patent_app_number] => 13/129597 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14420 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13129597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431199 [patent_doc_number] => 20100152113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'METAL-BINDING THERAPEUTIC PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/623242 [patent_app_country] => US [patent_app_date] => 2009-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 33038 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152113.pdf [firstpage_image] =>[orig_patent_app_number] => 12623242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245634 [patent_doc_number] => 20100136001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders' [patent_app_type] => utility [patent_app_number] => 12/592034 [patent_app_country] => US [patent_app_date] => 2009-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 44348 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136001.pdf [firstpage_image] =>[orig_patent_app_number] => 12592034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501484 [patent_doc_number] => 20110263498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'METHOD AND COMPOSITION FOR ENHANCEMENT OF MALE ERECTILE FUNCTION' [patent_app_type] => utility [patent_app_number] => 13/127889 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6853 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263498.pdf [firstpage_image] =>[orig_patent_app_number] => 13127889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8290567 [patent_doc_number] => 20120178901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'NUCLEIC ACIDS ENCODING PEPTIDES FOR TREATING WOUNDS, ANTI-ANGIOGENIC COMPOUNDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/126145 [patent_app_country] => US [patent_app_date] => 2009-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11221 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13126145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146880 [patent_doc_number] => 08163889 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Physiologically active polypeptide conjugate having prolonged in vivo half-life' [patent_app_type] => utility [patent_app_number] => 12/603757 [patent_app_country] => US [patent_app_date] => 2009-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15762 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163889.pdf [firstpage_image] =>[orig_patent_app_number] => 12603757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4496136 [patent_doc_number] => 07947655 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Methods for making proteins containing free cysteine residues' [patent_app_type] => utility [patent_app_number] => 12/604165 [patent_app_country] => US [patent_app_date] => 2009-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 41818 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947655.pdf [firstpage_image] =>[orig_patent_app_number] => 12604165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6467573 [patent_doc_number] => 20100040634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING HGF/MET' [patent_app_type] => utility [patent_app_number] => 12/582934 [patent_app_country] => US [patent_app_date] => 2009-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 33537 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040634.pdf [firstpage_image] =>[orig_patent_app_number] => 12582934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499463 [patent_doc_number] => 20110262446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'USE OF IGF-II/IGF-IIE BINDING PROTEINS FOR THE TREATMENT AND PREVENTION OF SYSTEMIC SCLEROSIS ASSOCIATED PULMONARY FIBROSIS' [patent_app_type] => utility [patent_app_number] => 13/124044 [patent_app_country] => US [patent_app_date] => 2009-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 45271 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262446.pdf [firstpage_image] =>[orig_patent_app_number] => 13124044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8689953 [patent_doc_number] => 08389480 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same' [patent_app_type] => utility [patent_app_number] => 12/558276 [patent_app_country] => US [patent_app_date] => 2009-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 41 [patent_no_of_words] => 26934 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12558276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7484592 [patent_doc_number] => 20110250230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'CELL CAPABLE OF EXPRESSING EXOGENOUS GITR LIGAND' [patent_app_type] => utility [patent_app_number] => 13/062999 [patent_app_country] => US [patent_app_date] => 2009-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9676 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20110250230.pdf [firstpage_image] =>[orig_patent_app_number] => 13062999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742431 [patent_doc_number] => 20120021040 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-01-26 [patent_title] => 'THERAPEUTIC AGENT FOR SPINAL CORD INJURIES' [patent_app_type] => utility [patent_app_number] => 12/548881 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9316 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0021/20120021040.pdf [firstpage_image] =>[orig_patent_app_number] => 12548881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742431 [patent_doc_number] => 20120021040 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-01-26 [patent_title] => 'THERAPEUTIC AGENT FOR SPINAL CORD INJURIES' [patent_app_type] => utility [patent_app_number] => 12/548881 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9316 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0021/20120021040.pdf [firstpage_image] =>[orig_patent_app_number] => 12548881 [rel_patent_id] =>[rel_patent_doc_number] =>)